📰 For Vitargus News
For Vitargus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from For Vitargus. Real-time updates on events, politics, business and more.
February 15, 2024
FREMONT, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it signed a definitive agreement to license certain of its healthcare-related expertise ("Know-How") to Senior Paradise, Inc. ("SPI"), who will also lease certain of the Company's properties (the &#...
February 8, 2024
FREMONT, CA, Feb. 08, 2024 -- via NewMediaWire – ABVC BioPharma, Inc. , a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and...
January 3, 2024
FREMONT, CA , Jan. 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) and its subsidiary BioLite, Inc. (
January 3, 2024
FREMONT, CA , Jan. 03, 2024 -- via NewMediaWire – ABVC BioPharma, Inc. and its subsidiary BioLite, Inc. , a clinical-stage biopharmaceutical company developing therapeutic solutions in...
October 9, 2023
The Company Holds a US Patent for the Same TreatmentFREMONT, CA, Oct. 09, 2023 (GLOBE NEWSWIRE) -- viaNewMediaWire -- ABVC BioPharma, Inc. (NASD...
October 9, 2023
The Company Holds a US Patent for the Same Treatment FREMONT, CA, Oct. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical
August 17, 2023
ABVC Executes Cooperation Agreement for Strategic Investments Fremont, CA, August 17, 2023 - ABVC BioPharma, Inc. , a clinical-stage biopharmaceutical company developing...
March 20, 2023
/PRNewswire/ -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS,...
March 14, 2023
/PRNewswire/ -- ABVC Biopharma, Inc. ("ABVC" or the "Company") (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
February 28, 2023
FREMONT, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology